LCGLA
MRK icon

LYNX CAPITAL GROUP LTD /ADV’s Merck MRK Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.55M Buy
+23,362
New +$2.43M 1.86% 18

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LYNX CAPITAL GROUP LTD /ADV's MRK Position: Q4 2023 in Review

LYNX CAPITAL GROUP LTD /ADV opened a new position in Merck (MRK) in Q4 2023: 23,362 shares worth $2.55M. The stake represents 1.86% of the portfolio and ranks #18 among its holdings.

3,436 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • LYNX CAPITAL GROUP LTD /ADV held 23,362 shares of Merck worth $2.55M as of Q4 2023.
  • Merck was a new LYNX CAPITAL GROUP LTD /ADV position in Q4 2023.
  • Merck made up 1.86% of LYNX CAPITAL GROUP LTD /ADV's portfolio in Q4 2023, its #18 holding.
  • 3,436 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2023, filed 7 Aug 2026.